Dialysis News and Research

Latest Dialysis News and Research

Carbamylation contributes to heart disease risk among patients with CKD undergoing dialysis

Kidney failure affects 25 million individuals in the U.S. and many more throughout the world. Loss of kidney function means the majority of these patients must undergo dialysis treatments to remove excess fluids and waste products. Although dialysis therapy coupled with medication has improved the life expectancy for people with kidney failure, for unknown reasons, patients' risk of sudden heart failure and death remains 10 to 20 times greater than average.

7 Mar 2013

OPKO Health acquires Cytochroma

OPKO Health, Inc. announced that it has completed the acquisition of Cytochroma Inc. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis.

4 Mar 2013

Lung congestion increases dialysis patients' risks of premature death or heart attacks

Asymptomatic lung congestion increases dialysis patients' risks of dying prematurely or experiencing heart attacks or other cardiac events, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

1 Mar 2013

LDL apheresis can reduce cholesterol levels in patients with familial hypercholesterolemia

Some patients are genetically prone to such dangerously high levels of cholesterol that no amount of diet, exercise and medications can reduce their cholesterol to safe levels.

1 Mar 2013

FDA alerts patients and health care providers of voluntary recall of Omontys by Affymax

The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfield, Ill.

25 Feb 2013

Catheters may increase risk of death, infections and cardiovascular events in dialysis patients

Dialysis patients using catheters to access the blood have the highest risks for death, infections, and cardiovascular events compared with patients using other types of vascular access, according to an analysis appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

22 Feb 2013

Studies confirm music therapy's positive effects on perceived quality of life

After 35 years as a music therapist, Anci Sandell can now present research findings showing that the therapy methods she uses, increases quality of life for people who are being treated for severe medical or psychosocial conditions.

21 Feb 2013

Frequent dialysis: it’s complicated

Patients who undergo hemodialysis on a frequent basis are at an increased risk for vascular access complications, requiring more vascular repair procedures to enable continued access to the blood, report Canadian researchers.

15 Feb 2013

State roundup: Calif. doc supply strains under health law

The compelling facts and figures he provided the Senate Finance Committee gave feuding Democrats and Republicans the confidence to unite behind an expedited but cautious roadmap toward a federally prescribed expansion of Medicaid in Virginia.

12 Feb 2013

WetAlert wireless wetness detector from Fresenius Medical Care

Fresenius Medical Care, the world's largest provider of dialysis products and services, announced today its introduction of the WetAlert wireless wetness detector, designed to detect venous needle displacement and prevent blood loss for dialysis patients at home.

11 Feb 2013

Frequent hemodialysis can cause vascular complications in patients

Compared with standard dialysis, frequent dialysis can cause complications related to repeated access to the blood, requiring patients to undergo more repair procedures to the site through which blood is removed and returned, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

10 Feb 2013

Omega-3 fatty acids can prevent sudden cardiac death in dialysis patients

Medical literature long has touted the benefits of omega-3 fatty acids for the heart. But until now, researchers have not studied the potential benefit for people on hemodialysis, who are among the highest-risk patients for sudden cardiac death.

9 Feb 2013

ZOLL's Intravascular Temperature Management solution receives Shonin approval in Japan

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has received Shonin approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) to enter the Japanese market with its Intravascular Temperature Management (IVTM) technology—the first intravascular temperature management system to receive Shonin approval in Japan.

6 Feb 2013

Chem-Aqua, Nephros partner to distribute new ultrafilters in North America

Nephros, Inc. and Chem-Aqua, Inc., a wholly owned water treatment subsidiary of NCH Corporation, announced today that the companies have signed a non-exclusive distributor agreement for Chem-Aqua to distribute Nephros's innovative ultrafilters in North America.

4 Feb 2013

Medicare expands competitive bidding program

The new prices will kick in July 1 and are expected to save on average 45 percent for products such as walkers, wheelchairs, oxygen equipment and other medical products.

2 Feb 2013

African-Americans without private health insurance less likely to receive kidney transplants

African-Americans and individuals without private health insurance are less likely than others to receive a kidney transplant before requiring dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

1 Feb 2013

Velomedix commences rapid therapeutic hypothermia system pilot study in heart attack

Velomedix, a venture-backed medical device company advancing the field of therapeutic hypothermia, today announced the enrollment of the first patient in its VELOCITY pilot study.

31 Jan 2013

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

Pfizer Inc. said today that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in RAPAMUNE®, for the inhibition of organ transplant rejection is valid and infringed.

31 Jan 2013

First Edition: January 31, 2013

Today's headlines include reports on a new health law final rule issued by the Internal Revenue Service eligibility and affordability standards for insurance subsidies.

31 Jan 2013

Keryx prices underwritten public offering of common stock

Keryx Biopharmaceuticals, Inc. today announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share.

30 Jan 2013

Dialysis News and Research

Latest Dialysis News and Research

Carbamylation contributes to heart disease risk among patients with CKD undergoing dialysis

OPKO Health acquires Cytochroma

Lung congestion increases dialysis patients' risks of premature death or heart attacks

LDL apheresis can reduce cholesterol levels in patients with familial hypercholesterolemia

FDA alerts patients and health care providers of voluntary recall of Omontys by Affymax

Catheters may increase risk of death, infections and cardiovascular events in dialysis patients

Studies confirm music therapy's positive effects on perceived quality of life

Frequent dialysis: it’s complicated

State roundup: Calif. doc supply strains under health law

WetAlert wireless wetness detector from Fresenius Medical Care

Frequent hemodialysis can cause vascular complications in patients

Omega-3 fatty acids can prevent sudden cardiac death in dialysis patients

ZOLL's Intravascular Temperature Management solution receives Shonin approval in Japan

Chem-Aqua, Nephros partner to distribute new ultrafilters in North America

Medicare expands competitive bidding program

African-Americans without private health insurance less likely to receive kidney transplants

Velomedix commences rapid therapeutic hypothermia system pilot study in heart attack

Delaware District Court rules in favor of Pfizer in RAPAMUNE patent case

First Edition: January 31, 2013

Keryx prices underwritten public offering of common stock

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in